Publication:
Is the Duration of Temozolomide Predictive for Sequential Bevacizumab Treatment Responses in the Glioblastoma Multiforme Cancer Setting?

Placeholder

Organizational Units

Program

Authors

Besiroglu, Mehmet
Demir, Tarik
Shbair, Abdallah T M
Yasin, Ayse Irem
Topcu, Atakan
Turk, HACI MEHMET

Advisor

Language

Publisher

Journal Title

Journal ISSN

Volume Title

Abstract

Description

Source:

Keywords:

Keywords

Citation

Besiroglu M., Demir T., Shbair A. T. M. , Yasin A. I. , Topcu A., Turk H. M. , -Is the Duration of Temozolomide Predictive for Sequential Bevacizumab Treatment Responses in the Glioblastoma Multiforme Cancer Setting?-, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, cilt.31, ss.932-936, 2021

Endorsement

Review

Supplemented By

Referenced By

0

Views

0

Downloads

View PlumX Details


Sustainable Development Goals